Your browser doesn't support javascript.
loading
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial.
Gensheimer, Michael F; Gee, Harriet; Shirato, Hiroki; Taguchi, Hiroshi; Snyder, John M; Chin, Alexander L; Vitzthum, Lucas K; Maxim, Peter G; Wakelee, Heather A; Neal, Joel; Das, Millie; Chang, Daniel T; Kidd, Elizabeth; Hancock, Steven L; Shultz, David B; Horst, Kathleen C; Le, Quynh-Thu; Wong, Samantha; Brown, Eleanor; Nguyen, Ngan; Liang, Rachel; Loo, Billy W; Diehn, Maximilian.
Afiliación
  • Gensheimer MF; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Gee H; Sydney West Radiation Oncology Network, Sydney, New South Wales, Australia.
  • Shirato H; University of Sydney, Sydney, New South Wales, Australia.
  • Taguchi H; Department of Radiation Oncology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Snyder JM; Department of Radiation Oncology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Chin AL; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Vitzthum LK; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Maxim PG; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Wakelee HA; Department of Radiation Oncology, University of California Irvine, Irvine, California.
  • Neal J; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Das M; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Chang DT; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Kidd E; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Hancock SL; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Shultz DB; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Horst KC; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Le QT; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Wong S; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Brown E; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Nguyen N; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Liang R; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Loo BW; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
  • Diehn M; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
JAMA Oncol ; 9(11): 1525-1534, 2023 Nov 01.
Article en En | MEDLINE | ID: mdl-37707820
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article